TOKYO, Apr 8, 2024 – (JCN Newswire) – NEC Corporation (TSE: 6701) has released a white paper, “Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines”. This white paper introduces (1) a comprehensive process workflow that can be applied to a wide range of processes…
Read More
